Good Therapeutics
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $31M
Investors
- 5
About Good Therapeutics
Good Therapeutics, Inc.Founded in 2016, Good Therapeutics, Inc. is based in Seattle, US, and specializes in creating regulated protein therapeutics. The company was recently acquired in September 2022 by F. Hoffmann-La Roche Ltd for USD 250 mn, marking a significant shift in their operational strategy. The acquisition is set to enhance Good Therapeutics' capabilities in immuno-oncology. The company has completed a total of 4 deals since its inception.Good Therapeutics, Inc. develops a novel class of regulated protein therapeutics, particularly focusing on antibody-controlled cytokines that enhance the anti-tumor immune response. Their innovative therapeutics remain inactive until they bind to specific targets, allowing for precise regulation of activity. The primary applications are in oncology, with potential extensions into autoimmune diseases, metabolic disorders, and pain management.Good Therapeutics, Inc. generates revenue through partnerships and collaborations with research institutions and pharmaceutical companies in the B2B sector. Revenue streams are driven by licensing agreements and milestone payments linked to the advancement of their therapeutic programs.The acquisition by Roche is expected to close in the third quarter of 2022, providing Good Therapeutics with substantial resources to advance its product pipeline. Following this transaction, the focus will be on integrating their active therapeutics with Roche’s immuno-oncology targets. Upcoming product launches are anticipated to leverage this integration to enhance treatment options in oncology.
Who invested in Good Therapeutics
5 investors across 3 rounds
See all investors in Good Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Good Therapeutics
Who invested in Good Therapeutics?
Good Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Good Therapeutics raised?
Good Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Good Therapeutics last raise money?
Good Therapeutics's most recent round on record is a Series B, in Dec 2021.
What does Good Therapeutics do?
Good Therapeutics is a biotechnology company.
Where is Good Therapeutics headquartered?
Good Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Good Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Good Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Good Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.